Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 28, 2020
Accession Number: 0001373707-20-000010
Submission Type: POS AM
CIK: 0001373707
Company Name: TETRAPHASE PHARMACEUTICALS INC
File Number: 333-214500